277 related articles for article (PubMed ID: 17996892)
1. Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway.
Herring N; Lokale MN; Danson EJ; Heaton DA; Paterson DJ
J Mol Cell Cardiol; 2008 Mar; 44(3):477-85. PubMed ID: 17996892
[TBL] [Abstract][Full Text] [Related]
2. The cardiac sympathetic co-transmitter galanin reduces acetylcholine release and vagal bradycardia: implications for neural control of cardiac excitability.
Herring N; Cranley J; Lokale MN; Li D; Shanks J; Alston EN; Girard BM; Carter E; Parsons RL; Habecker BA; Paterson DJ
J Mol Cell Cardiol; 2012 Mar; 52(3):667-76. PubMed ID: 22172449
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide-cGMP pathway facilitates acetylcholine release and bradycardia during vagal nerve stimulation in the guinea-pig in vitro.
Herring N; Paterson DJ
J Physiol; 2001 Sep; 535(Pt 2):507-18. PubMed ID: 11533140
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of prejunctional NPY receptor-mediated inhibition of cardiac neurotransmission.
Serone AP; Wright CE; Angus JA
Br J Pharmacol; 1999 May; 127(1):99-108. PubMed ID: 10369461
[TBL] [Abstract][Full Text] [Related]
5. Influence of endogenous neuropeptide Y (NPY) on the sympathetic-parasympathetic interaction in the canine heart.
Ilebekk A; Björkman JA; Nordlander M
J Cardiovasc Pharmacol; 2005 Oct; 46(4):474-80. PubMed ID: 16160600
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y inhibits acetylcholine release in human heart atrium by activation of Y2-receptors.
Schwertfeger E; Klein T; Vonend O; Oberhauser V; Stegbauer J; Rump LC
Naunyn Schmiedebergs Arch Pharmacol; 2004 May; 369(5):455-61. PubMed ID: 15103451
[TBL] [Abstract][Full Text] [Related]
7. Effects of a selective neuropeptide Y Y2 receptor antagonist, BIIE0246, on Y2 receptors at peripheral neuroeffector junctions.
Smith-White MA; Hardy TA; Brock JA; Potter EK
Br J Pharmacol; 2001 Feb; 132(4):861-8. PubMed ID: 11181427
[TBL] [Abstract][Full Text] [Related]
8. Natriuretic peptides like NO facilitate cardiac vagal neurotransmission and bradycardia via a cGMP pathway.
Herring N; Zaman JA; Paterson DJ
Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2318-27. PubMed ID: 11709398
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y is a prejunctional inhibitor of vagal but not sympathetic inotropic responses in guinea-pig isolated left atria.
Serone AP; Angus JA
Br J Pharmacol; 1999 May; 127(2):383-90. PubMed ID: 10385237
[TBL] [Abstract][Full Text] [Related]
10. Role of neuropeptide Y Y(2) receptors in modulation of cardiac parasympathetic neurotransmission.
Smith-White MA; Herzog H; Potter EK
Regul Pept; 2002 Feb; 103(2-3):105-11. PubMed ID: 11786149
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y1- and Y2-receptor-mediated cardiovascular effects in the anesthetized guinea pig, rat, and rabbit.
Abrahamsson C
J Cardiovasc Pharmacol; 2000 Oct; 36(4):451-8. PubMed ID: 11026645
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of vagal vasodilatation by a selective neuropeptide Y Y2 receptor agonist in the bronchial circulation of anaesthetised dogs.
Mahns DA; Lacroix JS; Potter EK
J Auton Nerv Syst; 1998 Nov; 73(2-3):80-5. PubMed ID: 9862381
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y regulates recurrent mossy fiber synaptic transmission less effectively in mice than in rats: Correlation with Y2 receptor plasticity.
Tu B; Jiao Y; Herzog H; Nadler JV
Neuroscience; 2006 Dec; 143(4):1085-94. PubMed ID: 17027162
[TBL] [Abstract][Full Text] [Related]
14. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.
Malmström RE; Lundberg JN; Weitzberg E
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):106-11. PubMed ID: 11819028
[TBL] [Abstract][Full Text] [Related]
15. Role of protein kinase C in mediating NGF effect on neuropeptide Y expression in PC12 cells.
Balbi D; Allen JM
Brain Res Mol Brain Res; 1994 Jun; 23(4):310-6. PubMed ID: 7522299
[TBL] [Abstract][Full Text] [Related]
16. Interaction between protein kinase C and protein kinase A can modulate transmitter release at the rat neuromuscular synapse.
Santafé MM; Garcia N; Lanuza MA; Tomàs M; Tomàs J
J Neurosci Res; 2009 Feb; 87(3):683-90. PubMed ID: 18816790
[TBL] [Abstract][Full Text] [Related]
17. Modulation by neuropeptide Y of parasympathetic nerve-evoked nasal vasodilatation via Y2 prejunctional receptor.
Lacroix JS; Ulman LG; Potter EK
Br J Pharmacol; 1994 Oct; 113(2):479-84. PubMed ID: 7834199
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y (NPY) and peptide YY (PYY) effects in the epididymis of the guinea-pig: evidence of a pre-junctional PYY-selective receptor.
Haynes JM; Hill SJ; Selbie LA
Br J Pharmacol; 1997 Dec; 122(7):1530-6. PubMed ID: 9421306
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cardiac vagal effects by neurally released and exogenous neuropeptide Y.
Warner MR; Levy MN
Circ Res; 1989 Dec; 65(6):1536-46. PubMed ID: 2582589
[TBL] [Abstract][Full Text] [Related]
20. Sites at which neuropeptide Y modulates parasympathetic control of heart rate in guinea pigs and rats.
Pardini BJ; Lund DD; Puk DE
J Auton Nerv Syst; 1992 May; 38(2):139-45. PubMed ID: 1619211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
